Papuga-Szela E - Search Results

1

Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Thrombocytopenia.

Janion-Sadowska A, Papuga-Szela E, Łukaszuk R, Chrapek M, Undas A. Janion-Sadowska A, et al. J Cardiovasc Pharmacol. 2018 Sep;72(3):153-160. doi: 10.1097/FJC.0000000000000607. J Cardiovasc Pharmacol. 2018. PMID: 29985282

2

Nonvitamin K Antagonist Oral Anticoagulant in Patients With Venous Thromboembolism and Polycythemia Vera or Essential Thrombocythemia: A Cohort Study.

Weronska A, Papuga-Szela E, Broniatowska E, Undas A. Weronska A, et al. Among authors: papuga szela e. J Cardiovasc Pharmacol. 2021 Nov 1;78(5):e743-e748. doi: 10.1097/FJC.0000000000001112. J Cardiovasc Pharmacol. 2021. PMID: 34321399

3

Direct oral anticoagulants in the treatment of cerebral venous sinus thrombosis: a single institution's experience.

Rusin G, Wypasek E, Papuga-Szela E, Żuk J, Undas A. Rusin G, et al. Among authors: papuga szela e. Neurol Neurochir Pol. 2019;53(5):384-387. doi: 10.5603/PJNNS.a2019.0037. Epub 2019 Aug 27. Neurol Neurochir Pol. 2019. PMID: 31454061

4

Efficacy and safety of non-vitamin K antagonist oral anticoagulants in very elderly patients with atrial fibrillation: a single-center experience.

Weronska A, Broniatowska E, Papuga-Szela E, Undas A. Weronska A, et al. Among authors: papuga szela e. Kardiol Pol. 2020 Feb 25;78(2):154-157. doi: 10.33963/KP.15135. Epub 2020 Jan 13. Kardiol Pol. 2020. PMID: 32108756 Free article. No abstract available.

5

Chronic Kidney Disease and Its Impact on a Prothrombotic State in Patients with Atrial Fibrillation.

Matusik PT, Heleniak Z, Papuga-Szela E, Plens K, Lelakowski J, Undas A. Matusik PT, et al. Among authors: papuga szela e. J Clin Med. 2020 Aug 1;9(8):2476. doi: 10.3390/jcm9082476. J Clin Med. 2020. PMID: 32752262 Free PMC article.

6

Direct oral anticoagulants in patients with severe inherited thrombophilia: a single-center cohort study.

Zuk J, Papuga-Szela E, Zareba L, Undas A. Zuk J, et al. Among authors: papuga szela e. Int J Hematol. 2021 Feb;113(2):190-198. doi: 10.1007/s12185-020-03012-7. Epub 2020 Oct 11. Int J Hematol. 2021. PMID: 33040276

7

Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Chronic Kidney Disease Stage G4: A Single-Center Experience.

Heleniak Z, Papuga-Szela E, Krzysztof P, Anetta U. Heleniak Z, et al. Among authors: papuga szela e. J Cardiovasc Pharmacol. 2020 Dec;76(6):671-677. doi: 10.1097/FJC.0000000000000911. J Cardiovasc Pharmacol. 2020. PMID: 33284572

8

Reduced‑dose apixaban and dabigatran in patients with advanced liver cirrhosis and venous thromboembolism: a case series.

Weronska A, Papuga-Szela E, Broniatowska E, Undas A. Weronska A, et al. Among authors: papuga szela e. Pol Arch Intern Med. 2021 Aug 30;131(7-8):762-765. doi: 10.20452/pamw.16024. Epub 2021 Jun 2. Pol Arch Intern Med. 2021. PMID: 34075737 Free article. No abstract available.

9

Correction to: Direct oral anticoagulants in patients with severe inherited thrombophilia: a single-center cohort study.

Zuk J, Papuga-Szela E, Zareba L, Undas A. Zuk J, et al. Among authors: papuga szela e. Int J Hematol. 2021 Mar;113(3):464-465. doi: 10.1007/s12185-020-03052-z. Int J Hematol. 2021. PMID: 33400144 No abstract available.

10

Altered Plasma Clot Properties and Trauma-Related Venous Thromboembolism despite Thromboprophylaxis.

Goldman S, Frączek P, Szklanny K, Papuga-Szela E, Stanisz A, Undas A. Goldman S, et al. Thromb Haemost. 2018 Apr;118(4):654-663. doi: 10.1055/s-0038-1636535. Epub 2018 Apr 4. Thromb Haemost. 2018. PMID: 29618152

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters